{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:38:01Z","timestamp":1780591081976,"version":"3.54.1"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T00:00:00Z","timestamp":1431561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0126297","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T18:02:12Z","timestamp":1431626532000},"page":"e0126297","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Randomized, Double-Blind, Crossover Trial of Amitriptyline for Analgesia in Painful HIV-Associated Sensory Neuropathy"],"prefix":"10.1371","volume":"10","clinical-trial-number":[{"clinical-trial-number":"isrctn54452526","registry":"10.18810\/isrctn"}],"author":[{"given":"Natalya","family":"Dinat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmore","family":"Marinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirra","family":"Moch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S. C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Kamerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,5,14]]},"reference":[{"key":"ref1","article-title":"Towards universal access: scaling up priority HIV\/AIDS interventions in the health sector [Internet]","year":"2010"},{"key":"ref2","unstructured":"World Health Organization (WHO). WHO model list of essential medicines: 18th list [Internet]. 2013 [cited 5 Feb 2013]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/18th_EML_Final_web_8Jul13.pdf\" xlink:type=\"simple\">http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/18th_EML_Final_web_8Jul13.pdf<\/ext-link>"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jpainsymman.2010.07.006","article-title":"HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans","volume":"41","author":"AL Wadley","year":"2011","journal-title":"J Pain Symptom Manag"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/mus.21535","article-title":"HIV neuropathy in South Africans: frequency, characteristics, and risk factors","volume":"41","author":"J Maritz","year":"2010","journal-title":"Muscle Nerve"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2217\/fvl.12.77","article-title":"HIV-associated sensory neuropathy: still a problem in the post-stavudine era?","volume":"7","author":"CL Cherry","year":"2012","journal-title":"Future Virol"},{"key":"ref6","first-page":"490","article-title":"Clin Infect Dis","volume":"53","author":"SA Mehta","year":"2011"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archneurol.2010.76","article-title":"Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study","volume":"67","author":"RJ Ellis","year":"2010","journal-title":"Arch Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1468-1293.2007.00478.x","article-title":"Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993\u20132006","volume":"8","author":"K Smyth","year":"2007","journal-title":"HIV Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.pain.2014.06.014","article-title":"Sensory, psychological, and metabolic dysfunction in HIV-associated peripheral neuropathy: A cross-sectional deep profiling study","volume":"155","author":"TJC Phillips","year":"2014","journal-title":"Pain"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e14433","DOI":"10.1371\/journal.pone.0014433","article-title":"Pharmacological treatment of painful HIV-associated sensory neuropathy: A systematic review and meta-analysis of randomised controlled trials","volume":"5","author":"TJC Phillips","year":"2010","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/QAI.0b013e31823e31f7","article-title":"A Randomized, Double-Blind, Controlled Study of NGX-4010, a Capsaicin 8% Dermal Patch, for the Treatment of Painful HIV-Associated Distal Sensory Polyneuropathy","volume":"59","author":"DB Clifford","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.pain.2014.05.027","article-title":"A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with HIV neuropathy","volume":"155","author":"DM Simpson","year":"2014","journal-title":"Pain"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"NB Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"key":"ref14","article-title":"World Health Organization (WHO) essential medicines lists","author":"PR Kamerman","year":"2015","journal-title":"Pain"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1001\/jama.280.18.1590","article-title":"Acupuncture and Amitriptyline for Pain Due to HIV-Related Peripheral Neuropathy: A Randomized Controlled Trial","volume":"280","author":"JC Shlay","year":"1998","journal-title":"J Am Med Assoc"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1212\/WNL.51.6.1682","article-title":"A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection","volume":"51","author":"K Kieburtz","year":"1998","journal-title":"Neurology"},{"key":"ref17","first-page":"1","article-title":"Palliative Care: symptom management and end-of-life care [Internet]","year":"2004","journal-title":"Palliative Care: symptom management and end-of-life care [Internet]"},{"key":"ref18","article-title":"Standard treatment guidelines and essential medicines list for South Africa [Internet]","year":"2012"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"N Attal","year":"2010","journal-title":"Eur J Neurol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11916-012-0257-z","article-title":"HIV-associated sensory neuropathy: Risk factors and genetics","volume":"16","author":"PR Kamerman","year":"2012","journal-title":"Curr Pain Headache Rep"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1529-8027.2012.00373.x","article-title":"Pathogenesis of HIV-associated sensory neuropathy: Evidence from in vivo and in vitro experimental models","volume":"17","author":"PR Kamerman","year":"2012","journal-title":"J Peripher Nerv Syst"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1212\/01.WNL.0000063304.88470.D9","article-title":"Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial","volume":"60","author":"DM Simpson","year":"2003","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/01.wnl.0000187119.33075.41","article-title":"Evaluation of a clinical screening tool for HIV-associated sensory neuropathies","volume":"65","author":"CL Cherry","year":"2005","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations","volume":"9","author":"RH Dworkin","year":"2008","journal-title":"J Pain"},{"key":"ref25","first-page":"397","article-title":"Drug therapy of depression and anxiety disorders","author":"M James","year":"2011","journal-title":"Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pain.2004.09.012","article-title":"Core outcome measures for chronic pain clinical trials: IMMPACT recommendations","volume":"113","author":"RH Dworkin","year":"2005","journal-title":"Pain"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jpainsymman.2007.10.020","article-title":"Validation of the Wisconsin Brief Pain Questionnaire in a Multilingual South African Population","volume":"36","author":"N Mphahlele","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1212\/WNL.0b013e3181ccc6ef","article-title":"Pregabalin for painful HIV neuropathy: A randomized, double-blind, placebo-controlled trial","volume":"74","author":"DM Simpson","year":"2010","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/SPC.0000000000000085","article-title":"Chronobiology of chronic pain: focus on diurnal rhythmicity of neuropathic pain","volume":"8","author":"I Gilron","year":"2014","journal-title":"Curr Opin Support Palliat Care"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/AJP.0b013e318275f287","article-title":"Chronobiological characteristics of neuropathic pain: clinical predictors of diurnal pain rhythmicity","volume":"29","author":"I Gilron","year":"2013","journal-title":"Clin J Pain"},{"key":"ref31","first-page":"1252","article-title":"Lancet","volume":"374","author":"I Gilron","year":"2009"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1526-4637.2012.01340.x","article-title":"Placebo Response Changes Depending on the Neuropathic Pain Syndrome: Results of a Systematic Review and Meta-Analysis","volume":"13","author":"MS Cepeda","year":"2012","journal-title":"Pain Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"15959","DOI":"10.1073\/pnas.1202056109","article-title":"Nonconscious activation of placebo and nocebo pain responses","volume":"109","author":"KB Jensen","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/ACM.0b013e3182086fe1","article-title":"Physicians\u2019 empathy and clinical outcomes for diabetic patients","volume":"86","author":"M Hojat","year":"2011","journal-title":"Acad Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/bmj.39524.439618.25","article-title":"Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome","volume":"336","author":"TJ Kaptchuk","year":"2008","journal-title":"BMJ"},{"key":"ref36","first-page":"494","article-title":"Practitioner empathy and the duration of the common cold","volume":"41","author":"DP Rakel","year":"2009","journal-title":"Fam Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pain.2010.06.019","article-title":"The evidence for pharmacological treatment of neuropathic pain","volume":"150","author":"NB Finnerup","year":"2010","journal-title":"Pain"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: An evidence based proposal","volume":"118","author":"NB Finnerup","year":"2005","journal-title":"Pain"},{"key":"ref39","first-page":"CD008242","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults","volume":"12","author":"RA Moore","year":"2012","journal-title":"Cochrane database Syst Rev"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0885-3924(99)00078-0","article-title":"Physicians\u2019 recognition of the symptoms experienced by HIV patients: How reliable?","volume":"18","author":"A Fontaine","year":"1999","journal-title":"J Pain Symptom Manage"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0126297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T23:58:44Z","timestamp":1717891124000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0126297"}},"subtitle":[],"editor":[{"given":"Michael Hoonbae","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,14]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0126297","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,14]]}}}